95 related articles for article (PubMed ID: 2556295)
1. Expression of the E. coli Lac Z gene from a defective HSV-1 vector in various human normal, cancer-prone and tumor cells.
Boothman DA; Geller AI; Pardee AB
FEBS Lett; 1989 Nov; 258(1):159-62. PubMed ID: 2556295
[TBL] [Abstract][Full Text] [Related]
2. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase.
Geller AI; Freese A
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1149-53. PubMed ID: 2153970
[TBL] [Abstract][Full Text] [Related]
3. A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons.
Geller AI; Breakefield XO
Science; 1988 Sep; 241(4873):1667-9. PubMed ID: 2843986
[TBL] [Abstract][Full Text] [Related]
4. Influence of the helper virus on expression of beta-galactosidase from a defective HSV-1 vector, pHSVlac.
Geller AI
J Virol Methods; 1991; 31(2-3):229-38. PubMed ID: 1650784
[TBL] [Abstract][Full Text] [Related]
5. A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters.
Geller AI
J Neurosci Methods; 1991 Jan; 36(1):91-103. PubMed ID: 1648153
[TBL] [Abstract][Full Text] [Related]
6. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.
Geller AI; Keyomarsi K; Bryan J; Pardee AB
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8950-4. PubMed ID: 2174168
[TBL] [Abstract][Full Text] [Related]
7. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI
Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207
[TBL] [Abstract][Full Text] [Related]
8. Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy.
Freese A; Geller A
Nucleic Acids Res; 1991 Dec; 19(25):7219-23. PubMed ID: 1662813
[TBL] [Abstract][Full Text] [Related]
9. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector.
Johnson PA; Yoshida K; Gage FH; Friedmann T
Brain Res Mol Brain Res; 1992 Jan; 12(1-3):95-102. PubMed ID: 1312210
[TBL] [Abstract][Full Text] [Related]
10. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
11. Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants.
Chiocca EA; Choi BB; Cai WZ; DeLuca NA; Schaffer PA; DiFiglia M; Breakefield XO; Martuza RL
New Biol; 1990 Aug; 2(8):739-46. PubMed ID: 2178004
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer in bovine blastocysts using replication-defective retroviral vectors packaged with Gibbon ape leukemia virus envelopes.
Kim T; Leibfried-Rutledge ML; First NL
Mol Reprod Dev; 1993 Jun; 35(2):105-13. PubMed ID: 8391277
[TBL] [Abstract][Full Text] [Related]
13. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector.
Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC
Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
Huard J; Goins WF; Glorioso JC
Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
[TBL] [Abstract][Full Text] [Related]
15. Cloning of replication-incompetent herpes simplex viruses as bacterial artificial chromosomes to facilitate development of vectors for gene delivery into differentiated neurons.
Schmeisser F; Weir JP
Hum Gene Ther; 2006 Jan; 17(1):93-104. PubMed ID: 16409128
[TBL] [Abstract][Full Text] [Related]
16. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis.
Liu Y; Rabinovitch A; Suarez-Pinzon W; Muhkerjee B; Brownlee M; Edelstein D; Federoff HJ
Hum Gene Ther; 1996 Sep; 7(14):1719-26. PubMed ID: 8886842
[TBL] [Abstract][Full Text] [Related]
17. Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors.
Kramm CM; Rainov NG; Sena-Esteves M; Chase M; Pechan PA; Chiocca EA; Breakefield XO
Hum Gene Ther; 1996 Feb; 7(3):291-300. PubMed ID: 8835217
[TBL] [Abstract][Full Text] [Related]
18. Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production.
Tung C; Federoff HJ; Brownlee M; Karpoff H; Weigel T; Brennan MF; Fong Y
Hum Gene Ther; 1996 Dec; 7(18):2217-24. PubMed ID: 8953312
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors.
Boviatsis EJ; Chase M; Wei MX; Tamiya T; Hurford RK; Kowall NW; Tepper RI; Breakefield XO; Chiocca EA
Hum Gene Ther; 1994 Feb; 5(2):183-91. PubMed ID: 8186298
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy of chondrosarcoma using retrovirus vectors encoding the herpes simplex virus thymidine kinase gene.
Seto M; Wakabayashi H; Yamazaki T; Sonoda J; Shinto Y; Uchida A
Int J Oncol; 1999 Jun; 14(6):1137-41. PubMed ID: 10339670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
